Skip to main content
. 2016 Nov 10;28(4):1239–1246. doi: 10.1681/ASN.2016040401

Table 5.

Associations (HRs and 95% CIs) of FGF23 with first infection-related hospitalization for the 881 participants in a random subgroup with measurements of markers of mineral metabolism

Model Quartile 1 <53.34 RU/ml, n=223 Quartile 2 =53.34–70.34 RU/ml, n=228 Quartile 3 =70.35–99.33 RU/ml, n=220 Quartile 4 >99.33 RU/ml, n=210 Per Doubling of FGF23
Model 1 Reference 1.25 (0.90 to 1.73) 1.50 (1.08 to 2.08) 2.96 (2.15 to 4.09) 1.61 (1.43 to 1.81)
Model 2 Reference 1.10 (0.79 to 1.53) 1.34 (0.96 to 1.88) 2.19 (1.54 to 3.13) 1.42 (1.24 to 1.63)
Model 3 Reference 1.07 (0.77 to 1.49) 1.27 (0.91 to 1.79) 2.07 (1.44 to 2.97) 1.37 (1.19 to 1.57)
Model 4a Reference 1.04 (0.75 to 1.45) 1.24 (0.88 to 1.75) 2.02 (1.41 to 2.91) 1.35 (1.17 to 1.55)
Model 4b Reference 1.04 (0.74 to 1.45) 1.25 (0.89 to 1.75) 1.99 (1.38 to 2.86) 1.34 (1.17 to 1.55)

Model 1: age, race, and sex. Model 2: model 1, smoking status, BMI, diabetes, CHD, CHF, eGFR (cystatin C equation), and urine ACR. Model 3: model 2, albumin, CRP, and IL-6. Model 4a: model 3, calcium, phosphorus, 25(OH)D, iPTH, and 24,25(OH)2D. Model 4b: model 3, calcium, phosphorus, iPTH, and the VMR [24,25(OH)2D-to-25(OH)D ratio]. RU, relative unit.